News | Cardiovascular Ultrasound | January 27, 2016

AMA Assigns New Investigational CPT Code for Myocardial Strain Imaging

Category III code meant to encourage further use of strain imaging in cardiology, cardio-oncology applications

AMA, investigational CPT code, myocardial strain imaging, cardio-oncology

January 27, 2016 — Effective Jan. 1, 2016, the American Medical Association (AMA) Current Procedural Terminology (CPT) Editorial Panel assigned a new category III CPT code, 0399T, for use in reporting myocardial strain imaging for the detection of myocardial deformation. While Category III codes generally are not initially reimbursed, they often become payable when they are used routinely in clinical practice.

Research has shown that strain imaging can improve diagnostic assessment, standardize interpretation and assist in improving the monitoring of patients over time to optimize care. Additionally, measurements derived from strain imaging have been shown to be more sensitive and less variable than gold standard measurements like EF, making it increasingly important.

American Society of Echocardiography (ASE) chamber quantification guidelines now recommend strain imaging when assessing function. ASE recommendations for assessment and monitoring with echo of cardio-oncology patients indicate strain imaging should be monitored in this patient population.

The ACVI/ASE/Industry Task Force to Standardize Deformation Imaging issued definitions to improve standardization of 2-D speckle tracking measurements.

Increasingly, studies show that assessing and monitoring strain may improve quality of patient care and reduce costs with patient readmissions.

Although strain imaging has proven to be valuable in the assessment and management of patients with echo, until now, diagnostic software solutions with strain imaging have been research-oriented, laborious and workflow-inefficient in clinical practice.

EchoInsight is among the companies pushing for increased usage of strain imaging to improve diagnostic confidence, standardization and efficiency. Epsilon Imaging’s proprietary speckle tracking technology, TissueTrack, provides robust strain imaging with automation of cardiac functional measurements. It provides clinical strain imaging for improved confidence in assessment and monitoring of wall mechanics for the entire heart. It is available as a stand-alone workstation or client-server architecture using a vendor neutral platform.

For more information: www.epsilon-imaging.com


Related Content

News | Cardio-oncology

February 1, 2023 — The International Cardio-Oncology Society has awarded University Hospitals (UH) Harrington Heart & ...

Home February 01, 2023
Home
News | Cardio-oncology

May 23, 2022 — New data from a study of more than 100 million hospitalizations using machine learning augmentation was ...

Home May 23, 2022
Home
News | Cardio-oncology

February 25, 2020 — Results of a multi-centre, international, clinical trial co-led by Peter Munk Cardiac Centre (PMCC) ...

Home February 25, 2021
Home
News | Cardio-oncology

July 29, 2019 — Cancer patients taking cholesterol-lowering statin medication following radiation therapy of the chest ...

Home July 29, 2019
Home
Videos | Cardio-oncology

Magid Awadalla, MBBS, is an advanced cardiac imaging research fellow at Massachusetts General Hospital. He has been ...

Home March 22, 2019
Home
News | Cardio-oncology

March 13, 2019 — An imaging procedure commonly performed before starting cancer treatment can provide valuable clues ...

Home March 13, 2019
Home
News | Cardio-oncology

January 28, 2019 — The American College of Cardiology host the third Advancing the Cardiovascular Care of the Oncology ...

Home January 28, 2019
Home
News | Cardio-oncology

January 3, 2019 — Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage ...

Home January 03, 2019
Home
News | Cardio-oncology

December 21, 2018 — Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to ...

Home December 21, 2018
Home
News | Cardio-oncology

December 7, 2018 — New data from the Phase 3 CASSINI study showed a 60 percent reduction of venous thromboembolism (VTE ...

Home December 07, 2018
Home
Subscribe Now